Stock data
Astellas Pharma$10.07
4503 
0.35% • 24 H
0.35% • 24 HDividend Yield:3.5%
Global Rank#938
Market Cap$18.33B
YTD Performance-7.84%
P/E0.19
Revenue$9.67B
Change 7d1.05%
SP500 BenchmarkUnderperform
Country🇯🇵 Japan
P/S1.90
Earnings$628.57M
Dividend Yield:3.5%
Main Sector
Healthcare
EPS for Astellas Pharma (4503)
Astellas Pharma has an EPS of $54.09. In 2022, the company made an earnings per share (EPS) of $67.05. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 4503
-
Value:-
EPS history for Astellas Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $54.09 | -19.33% |
| 2022 | $67.05 | 3.31% |
| 2021 | $64.90 | -37.64% |
| 2020 | $104.08 | - |
View the highest EPS stocks
